van der Wilt Clasina L, Smid Kees, Peters Godefridus J
Department of Medical Oncology, VU University, Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands.
Biochem Pharmacol. 2002 Aug 15;64(4):669-75. doi: 10.1016/s0006-2952(02)01219-4.
Folate based inhibitors of thymidylate synthase (TS) might facilitate binding of 5-fluoro-2'-deoxyuridine-5'-monophosphate (FdUMP) to TS similar to the natural reduced folate 5,10-methylenetetrahydrofolate (CH(2)-H(4)-folate). We studied the lipophilic, non-polyglutamatable antifolates Nolatrexed (NTX) and AG331 and antifolates, that can have a polyglutamate side chain like the natural folate CH(2)-H(4)-folate; GW1843U89, Raltitrexed (RTX) and Multi-targetted antifolate (MTA) and pentaglutamates (RTX-Glu(5) and MTA-Glu(5)). The capacity of these compounds to facilitate the binding of [(3)H]FdUMP to Lactobacillus casei TS and an ammoniumsulphate precipitate of human TS was investigated. Only NTX, RTX-Glu(5) and MTA-Glu(5) facilitated FdUMP binding to L. casei TS and their dissociation constant K(d) (0.2-0.7 microM) was low compared to CH(2)-H(4)-folate (2.0 microM). The small lipophilic molecule NTX was favorable to the larger AG331. Polyglutamylation, as indicated by the difference in effect of RTX vs. RTX-Glu(5) and MTA vs. MTA-Glu(5), seems to be important for a classical antifolate to facilitate binding of FdUMP to bacterial TS. Effects of antifolates on FdUMP binding to human TS were different. At a low concentration (0.05 microM) NTX, RTX-Glu(5) and MTA-Glu(5) facilitated 3-5 times higher binding of [(3)H]FdUMP to TS than CH(2)-H(4)-folate. At higher concentrations (0.3-5 microM) of NTX, RTX-Glu(5) and MTA-Glu(5) the FdUMP binding decreased. The complex remained stable in the absence of (anti)folate for at least 24hr. The K(d) values of the antifolates for human TS varied from 19 to 387 nM, while the K(d) of CH(2)-H(4)-folate for human TS was 351 nM. The Hill coefficients, which indicated the type of cooperativity of the antifolates in the binding of FdUMP to TS were positive (0.58-0.99) at low concentrations (<0.3 microM) and negative (-0.35 to -0.81) at concentrations >0.3 microM except for GW1843U89, which only showed negative cooperativity (-1.70). It was shown with [(14)C]NTX that when the binding of FdUMP decreased at high NTX concentrations, the binding of NTX to TS still increased. This also held for the natural substrate dUMP. The negative cooperativity of the antifolates was clearly concentration dependent. The difference between human and L. casei TS in the FdUMP binding assays with antifolates can possibly be explained by interaction of the two subunits of human TS, which was absent in L. casei TS. The binding of antifolates to one of the two subunits induced a conformational change of the other subunit. This change no longer allowed the binding of FdUMP or dUMP at the active site. In conclusion this study showed that antifolates enhanced the binding of FdUMP to TS, especially at low antifolate concentrations, that are also clinically achievable, e.g. in human plasma.
基于叶酸的胸苷酸合酶(TS)抑制剂可能会促进5-氟-2'-脱氧尿苷-5'-单磷酸(FdUMP)与TS的结合,类似于天然还原叶酸5,10-亚甲基四氢叶酸(CH(2)-H(4)-叶酸)。我们研究了亲脂性、不可聚谷氨酸化的抗叶酸药物诺拉曲塞(NTX)和AG331,以及可具有类似天然叶酸CH(2)-H(4)-叶酸的聚谷氨酸侧链的抗叶酸药物;GW1843U89、雷替曲塞(RTX)和多靶点抗叶酸药物(MTA)以及五聚谷氨酸(RTX-Glu(5)和MTA-Glu(5))。研究了这些化合物促进[(3)H]FdUMP与干酪乳杆菌TS及人TS硫酸铵沉淀物结合的能力。只有NTX、RTX-Glu(5)和MTA-Glu(5)促进了FdUMP与干酪乳杆菌TS的结合,与CH(2)-H(4)-叶酸(2.0 microM)相比,它们的解离常数K(d)(0.2 - 0.7 microM)较低。亲脂性小分子NTX比更大的AG331更具优势。如RTX与RTX-Glu(5)以及MTA与MTA-Glu(5)效果差异所示,聚谷氨酸化对于经典抗叶酸药物促进FdUMP与细菌TS的结合似乎很重要。抗叶酸药物对FdUMP与人TS结合的影响有所不同。在低浓度(0.05 microM)时,NTX、RTX-Glu(5)和MTA-Glu(5)促进[(3)H]FdUMP与TS的结合比CH(2)-H(4)-叶酸高3 - 5倍。在NTX、RTX-Glu(5)和MTA-Glu(5)的较高浓度(0.3 - 5 microM)下,FdUMP结合减少。复合物在无(抗)叶酸的情况下至少24小时保持稳定。抗叶酸药物与人TS的K(d)值在19至387 nM之间变化,而CH(2)-H(4)-叶酸与人TS的K(d)为351 nM。希尔系数表明抗叶酸药物在FdUMP与TS结合中的协同作用类型,在低浓度(<0.3 microM)时为正(0.58 - 0.99),在浓度>0.3 microM时为负(-0.35至-0.81),除了GW1843U89仅显示负协同作用(-1.70)。用[(14)C]NTX表明,当在高NTX浓度下FdUMP结合减少时,NTX与TS的结合仍在增加。天然底物dUMP也是如此。抗叶酸药物的负协同作用明显依赖于浓度。在抗叶酸药物的FdUMP结合试验中,人TS和干酪乳杆菌TS之间的差异可能可以通过人TS的两个亚基之间的相互作用来解释,而干酪乳杆菌TS中不存在这种相互作用。抗叶酸药物与两个亚基之一的结合会诱导另一个亚基的构象变化。这种变化不再允许FdUMP或dUMP在活性位点结合。总之,这项研究表明抗叶酸药物增强了FdUMP与TS的结合,尤其是在低抗叶酸药物浓度下,而这种浓度在临床上也是可以达到的,例如在人血浆中。